Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.
about
Tissue MicroArray (TMA) analysis of normal and persistent Chlamydophila pneumoniae infectionAtherosclerosis and infection: is the jury still not in?Role of Helicobacter pylori infection in pathogenesis of atherosclerosisChlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertensionImmunity, atherosclerosis and cardiovascular diseaseHuman oral, gut, and plaque microbiota in patients with atherosclerosis.C-reactive protein as a marker for active coronary artery disease in patients with chest pain in the emergency room.Role of NOD2/CARD15 in coronary heart disease.Evaluation and optimization of a commercial enzyme linked immunosorbent assay for detection of Chlamydophila pneumoniae IgA antibodiesChlamydia pneumoniae and atherosclerosis.Chlamydia pneumoniae enhances cytokine-stimulated human monocyte matrix metalloproteinases through a prostaglandin E2-dependent mechanism.Acute hemorrhagic pericarditis in a child with pneumonia due to Chlamydophila pneumoniae.Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro.Is cardiovascular disease preventable by vaccination?Long term vascular complications of Coxiella burnetii infection in Switzerland: cohort study.Mortality increase in late-middle and early-old age: heterogeneity in death processes as a new explanation.Chlamydia pneumoniae and coronary heart disease.Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice.Influence of periodontal infections on systemic health.Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland.Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus: chronic infections and coronary heart disease.Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease?Effects of a probiotic strain of Enterococcus faecium on the rate of natural chlamydia infection in swine.Chlamydia pneumoniae in atherosclerosis.Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studiesInfections and atherosclerosis.Epidemiologic association of Chlamydia pneumoniae and atherosclerosis: the initial serologic observation and more.Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology.Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells.Infection and inflammation-induced proatherogenic changes of lipoproteins.Growth in vascular cells and cytokine production by Chlamydia pneumoniae.Antibiotics in the prevention and treatment of coronary heart disease.Optimizing culture of Chlamydia pneumoniae by using multiple centrifugations.Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCRMulticenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens.Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individualsAtherosclerosis: an infectious disease?Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection.Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice.Weighing the evidence for infection as a risk factor for coronary heart disease.
P2860
Q21261768-5E00DB88-00A4-4DB8-96CD-2E82DAE18107Q22241306-7F63BFFD-40AA-4873-A311-DE26E899CC16Q27002402-25EB3160-AC57-492E-A754-83F6CCE90F81Q28182623-5368BA6C-F370-4B29-AF25-DFF94CE09EB6Q28688590-AC834FAB-5ACD-4D8C-8BF6-C3009EF22CBEQ30499024-89D025A6-1CBF-4983-8BBC-E1410607A396Q31113902-73323F0D-3882-4381-ACB5-7D30E58B5E89Q33304877-D0C9B4AA-5257-4F85-9FC3-D30EFFC8E599Q33355197-660373A5-EE86-4920-88ED-7221AB3449DCQ33534714-585F4D1E-7986-4F9B-93A1-8EE82398B2F9Q33556766-D434B23A-0AF6-4AB1-A1A0-74B4466109A4Q33592551-1EA5D6A7-A45E-4CF1-BDAB-6B7454A69DA9Q33597752-FAB47A7C-584B-46C7-90D3-800E37888A12Q33603398-0A1A93F2-1B74-48FF-8653-7972228915DDQ33634694-35EF5858-E98A-46E7-901C-5E2F63111B1BQ33640371-FBE7069D-7F49-49EB-B8D6-AD9CA07803B3Q33659387-225B68CA-FE58-4E33-8E45-B5587232FD27Q33756547-BC4595A0-3333-490A-B747-49C6446DBA3BQ33768655-12C82A15-26B1-4468-A913-0B79104064EDQ33788646-8B628F6B-DBC1-41C0-A473-277FBDAC2120Q33821315-F1A7CA15-C3B5-4959-8DA0-D4C4AC93372BQ33871329-D3CB1A88-9D94-4F6E-B6DF-A4A41E99390AQ33883364-47F21B20-744D-4A4D-A336-C682FF224734Q33890410-3545504F-5FA9-45F3-9166-C9DB04DA16A3Q33905858-E132AEF4-8988-470C-9742-80315DB8CF0CQ33921219-803C1513-0796-4A7E-8191-604BAF2B4B5AQ33935008-F825C56A-D3FE-4E2F-BF67-957C0E27B75CQ33935019-E22282A9-10A9-4377-9E24-ECF3825193D9Q33935030-D94CB61F-EDA6-4A61-89A5-59CC10C22E91Q33935040-824F71F4-F039-4265-9BBE-36942C4A9BDAQ33935046-BA36E699-56E7-4108-B538-2512F29D4705Q33935098-7B0E9AAF-88CC-466B-9B08-2F45C65130F8Q33963149-5FFBEA8B-C560-4D16-A5CF-A8A1AD5417CDQ33970537-EEBBCFC8-A4E3-4B6E-A36C-3071D6647359Q33971158-B71627FC-5140-4541-8335-0EB90C3031ECQ33972282-E47B32C9-CAB4-4F15-8228-4518F1B239ECQ33972834-6BE36DCC-9A6C-4F5F-A641-F06940704EFBQ34004010-A482DA49-7E59-4B1E-B719-187D7671FE79Q34007947-2CD50DBC-75DB-4CED-86D2-DA363840BCBBQ34011168-F27A3452-8CE5-4B20-988E-C04D71FC2982
P2860
Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic Chlamydia pneumoniae i ...... e in the Helsinki Heart Study.
@en
Chronic Chlamydia pneumoniae i ...... e in the Helsinki Heart Study.
@nl
type
label
Chronic Chlamydia pneumoniae i ...... e in the Helsinki Heart Study.
@en
Chronic Chlamydia pneumoniae i ...... e in the Helsinki Heart Study.
@nl
prefLabel
Chronic Chlamydia pneumoniae i ...... e in the Helsinki Heart Study.
@en
Chronic Chlamydia pneumoniae i ...... e in the Helsinki Heart Study.
@nl
P2093
P1476
Chronic Chlamydia pneumoniae i ...... e in the Helsinki Heart Study.
@en
P2093
Huttunen JK
Leinonen M
Linnanmäki E
Manninen V
Mänttäri M
Tenkanen L
P304
P356
10.7326/0003-4819-116-4-273
P407
P577
1992-02-01T00:00:00Z